HZ
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
26.632
Exchange
XNAS - Nasdaq
110 %
Last period Net income growth rate
22%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Horizon Therapeutics
Company Analysis
HZNP valuation, rating, competitors, insights and company profile
Eyestock Rating
HZNP financial analysis by Eyestock methodology
Valuation
HZNP valuation using historical relative method
Statements
HZNP Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HZNP dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Horizon Therapeutics`s Net income growth rate for the period ended 2023-06-30 is 110 %
